Evidence map›Paper›PMID 40888831›Full record

ArticleJournal of cancer survivorship : research and practice2025

Using machine learning to identify speech markers of subjective cognitive impairment in breast cancer survivors.

Amélie B Richard, Alexandre Foncelle, Sophie Jacquin-Courtois, Pauline Mouchès

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amélie B RichardUniversité Montpellier Paul-Valéry, Praxiling CNRS UMR5267, Route de Mende, 34199, Montpellier cedex 5, France. amelie.richard@univ-montp3.fr.ORCID http://orcid.org/0000-0002-5892-6215
Alexandre FoncelleUniversité de Lyon, Université Lyon 1, INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Centre, F-69676, Bron, France.
Sophie Jacquin-CourtoisUniversité de Lyon, Université Lyon 1, INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Centre, F-69676, Bron, France.
Pauline MouchèsUniversité de Lyon, Université Lyon 1, INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Centre, F-69676, Bron, France.ORCID http://orcid.org/0000-0002-0304-5584

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCancer-related cognitive impairment (CRCI) refers to cognitive changes described by cancer patients. While subjective cognitive difficulties in survivors are well screened by questionnaires, CRCI remains seldom diagnosed by neuropsychological tests. New objective approaches are needed to detect CRCI. The goal of this study is to find the speech markers that can best detect CRCI.

methodsForty-four women who completed breast cancer treatment and 13 controls were asked to narrate a picture-based story. Speech productions were recorded and analyzed using semi-automatic methods. Fourteen speech features were extracted and incorporated in machine learning models to classify CRCI assessed using the FACT-Cog questionnaire. In addition, all participants underwent psychological assessment to control for confounding factors.

resultsThe combination of speech-to-silence ratio, mean duration of silent pauses, and mean duration of filled pauses best predicted cancer survivors with CRCI (ROC = 0.74, accuracy = 73.7%). Bayesian Generalized Linear Models further showed that silence in participants' speech depended on whether they had CRCI and reported depression assessed using the HADS. Credibility Intervals of regression coefficients showed only a trend for reported depression (95% CI [- 0.36, - 0.00]), while scores were below clinical thresholds for depressive disorders for all groups.

conclusionsLong silent pauses in discourse may be a sign of cancer-related cognitive impairment in survivors of breast cancer. IMPLICATIONS FOR CANCER SURVIVORS: This study demonstrates the benefits of using speech analysis as a fast, ecological, and non-invasive technique for assessing CRCI.

Indexed as

Breast cancerCognitive changesDiagnosisMachine learningSpeech

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.